(Q54378706)

English

Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution. (English)

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

chemoradiotherapy

0 references

0 references

1 reference

based on heuristic

inferred from title

Dominique Figarella-Branger

12

object named as

Dominique Figarella-Branger

1 reference

Europe PubMed Central

29 May 2018

author name string

Philippe Metellus

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Isabelle Nanni-Metellus

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Christine Delfino

3

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Carole Colin

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Aurelie Tchogandjian

5

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Bema Coulibaly

6

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Frederic Fina

7

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Anderson Loundou

8

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Marylin Barrie

9

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Olivier Chinot

10

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

L'houcine Ouafik

11

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

publication date

9 April 2011

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Annals of Surgical Oncology

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

18

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

2937-2945

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

10

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

https://scigraph.springernature.com/pub.10.1245/s10434-011-1703-6

0 references

Neural stem cells and the origin of gliomas

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Brain tumour stem cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Identification of human brain tumour initiating cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Targeting cancer stem cells through L1CAM suppresses glioma growth

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

A2B5 cells from human glioblastoma have cancer stem cell properties

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Chemotherapy resistance of glioblastoma stem cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Stem cell marker CD133 affects clinical outcome in glioma patients.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

The 2007 WHO classification of tumours of the central nervous system

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Neurosphere formation is an independent predictor of clinical outcome in malignant glioma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Presence of pluripotent CD133+ cells correlates with malignancy of gliomas.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Temozolomide preferentially depletes cancer stem cells in glioblastoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1703-6

21 January 2018

Identifiers

10.1245/S10434-011-1703-6

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21479688

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54378706&oldid=1534683180"